| Hans-Günter Meyer-Thompson | Cannabis als Medizin
The Use of Tetrahydrocannabinol Is Associated with an Increase in Survival Time in Palliative Cancer Patients: A Retrospective Multicenter Cohort Study.
The Use of Tetrahydrocannabinol Is Associated with an Increase in Survival Time in Palliative Cancer Patients: A Retrospective Multicenter Cohort Study.
Gastmeier K, Gastmeier A, Schwab F, Herdegen T.
Med Cannabis Cannabinoids. 2024 Mar 14;7(1):59-67. doi: 10.1159/000538311. PMID: 38655402; PMCID: PMC11037891.